Literature DB >> 35953593

Dietary intake of beans and risk of disabling dementia: The Circulatory Risk in Communities Study (CIRCS).

Rie Kishida1, Kazumasa Yamagishi2,3,4, Koutatsu Maruyama5, Chika Okada6, Mari Tanaka6,7, Ai Ikeda8, Mina Hayama-Terada9, Yuji Shimizu10, Isao Muraki6, Mitsumasa Umesawa11, Hironori Imano10,6,7, Eric J Brunner12, Tomoko Sankai13, Takeo Okada10, Akihiko Kitamura9, Masahiko Kiyama10, Hiroyasu Iso6,14.   

Abstract

OBJECTIVE: To examine whether bean intake (including soybeans) among Japanese adults is associated with risk of disabling dementia severe enough to require care under the national insurance system.
METHODS: This cohort study involved 3739 individuals aged 40 to 64 years. The participants were categorized into five groups based on their dietary bean intake estimated by a 24h dietary recall. Hazard ratios and 95% confidence intervals of disabling dementia were estimated using Cox proportional hazard models adjusted for potential confounding factors (smoking, drinking, and intakes of energy and fish).
RESULTS: During the 59,681 person-year follow-up, 670 cases of disabling dementia were observed. A weak inverse association between bean intake and risk of disabling dementia was found; the multivariable hazard ratios (95% CIs) were 0.79 (0.62-1.00), 0.80 (0.63-1.01), 0.84 (0.67-1.06), and 0.78 (0.62-0.99) for the four groups with higher bean intake, respectively, compared with the lowest group (P for trend = 0.21). A significant inverse association was observed for dementia without a history of stroke; for the four groups with higher bean intake the multivariable hazard ratios were 0.81 (0.61-1.08), 0.70 (0.52-0.95), 0.71 (0.52-0.95), and 0.69 (0.51-0.92), respectively, (P for trend = 0.03). No such association was observed for dementia with history of stroke. The group with increased natto intake were inversely associated with risk of disabling dementia (P for trend = 0.003), but tofu intake was not (P for trend = 0.19).
CONCLUSIONS: Bean intake was inversely associated with risk of disabling dementia in those without a history of stroke.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2022        PMID: 35953593     DOI: 10.1038/s41430-022-01188-1

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.884


  2 in total

1.  Antagonizing effects of soybean isoflavones on β-amyloid peptide-induced oxidative damage in neuron mitochondria of rats.

Authors:  Jin-Fang Feng; Ling-Ling He; Dan Li; Lin-Hong Yuan; Huan-Ling Yu; Wei-Wei Ma; Yue Yang; Yuan-Di Xi; Juan Ding; Yi-Xiu Xiao; Rong Xiao
Journal:  Basic Clin Pharmacol Toxicol       Date:  2012-10       Impact factor: 4.080

Review 2.  Dietary soybean isoflavones in Alzheimer's disease prevention.

Authors:  Yanhui Lu; Yu An; Chenyan Lv; Weiwei Ma; Yuandi Xi; Rong Xiao
Journal:  Asia Pac J Clin Nutr       Date:  2018       Impact factor: 1.662

  2 in total
  1 in total

1.  Potentially inappropriate medications are negatively associated with functional recovery in patients with sarcopenia after stroke.

Authors:  Ayaka Matsumoto; Yoshihiro Yoshimura; Fumihiko Nagano; Sayuri Shimazu; Ai Shiraishi; Yoshifumi Kido; Takahiro Bise
Journal:  Aging Clin Exp Res       Date:  2022-08-29       Impact factor: 4.481

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.